Sonoma Pharmaceuticals Announces U.S. Commercialization of Loyon® for Relief of Scaling, Burning and Itching Associated with Various Dermatoses Including Seborrhea and Seborrheic Dermatitis Oct 3, 2017
Sonoma Pharmaceuticals Announces Commercialization of MicrocynAH® Animal Healthcare Products in Japan Sep 14, 2017
Sonoma Pharmaceuticals Announces Fiscal First Quarter 2018 Financial Results and Conference Call Jul 25, 2017
CORRECTING and REPLACING -- Sonoma Pharmaceuticals Announces Record Quarterly Prescription Data Jul 13, 2017
Sonoma Pharmaceuticals Announces Publication of Consensus Report Describing Celacyn's (Hypochlorous Acid) Impact on Post-Procedure Treatment and Scar Prevention Jun 28, 2017
Sonoma Pharmaceuticals Announces Two Singapore Approvals for Microcyn® (hypochlorous acid) for the Treatment of Atopic Dermatitis and Hypertrophic / Keloid Scars Jun 20, 2017
Sonoma Pharmaceuticals Announces Fiscal Year/Fourth Quarter 2017 Financial Results and Conference Call Jun 2, 2017
